» Articles » PMID: 19777586

Serum-free, Chemically Defined Medium with TGF-beta(3) Enhances Functional Properties of Nucleus Pulposus Cell-laden Carboxymethylcellulose Hydrogel Constructs

Overview
Publisher Wiley
Specialty Biochemistry
Date 2009 Sep 25
PMID 19777586
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Degeneration of the nucleus pulposus (NP) has been implicated as a major cause of low back pain. Tissue engineering strategies may provide a viable NP replacement therapy; however, culture conditions must be optimized to promote functional tissue development. In this study, a standard serum-containing medium formulation was compared to a chemically defined, serum-free medium to determine the effect on matrix elaboration and functional properties of NP cell-laden carboxymethylcellulose (CMC) hydrogels. Additionally, both media were further supplemented with transforming growth factor-beta 3 (TGF-beta(3)). Glycosaminoglycan (GAG) content increased in both TGF-beta(3)-treated groups and was highest for treated, serum-free constructs (9.46 +/- 1.51 microg GAG/mg wet weight), while there were no quantifiable GAGs in untreated serum-containing samples. Histology revealed uniform, interterritorial staining for chondroitin sulfate proteoglycan throughout the treated, serum-free constructs. Type II collagen content was greater in both serum-free groups and highest in treated, serum-free constructs. The equilibrium Young's modulus was highest in serum-free samples supplemented with TGF-beta(3) (18.54 +/- 1.92 kPa), and the equilibrium weight swelling ratio of these constructs approached that of the native NP tissue (22.19 +/- 0.46 vs. 19.94 +/- 3.09, respectively). Taken together, these results demonstrate enhanced functional matrix development by NP cells when cultured in CMC hydrogels maintained in serum-free, TGF-beta(3) supplemented medium, indicating the importance of medium formulation in NP construct development.

Citing Articles

Combining adhesive and nonadhesive injectable hydrogels for intervertebral disc repair in an ovine discectomy model.

Panebianco C, Constant C, Vernengo A, Nehrbass D, Gehweiler D, DiStefano T JOR Spine. 2023; 6(4):e1293.

PMID: 38156055 PMC: 10751969. DOI: 10.1002/jsp2.1293.


Review of the Current Research on Fetal Bovine Serum and the Development of Cultured Meat.

Lee D, Lee S, Yun S, Jeong J, Kim J, Kim H Food Sci Anim Resour. 2022; 42(5):775-799.

PMID: 36133630 PMC: 9478980. DOI: 10.5851/kosfa.2022.e46.


Balancing biological and biomechanical performance in intervertebral disc repair: a systematic review of injectable cell delivery biomaterials.

Panebianco C, Meyers J, Gansau J, Hom W, Iatridis J Eur Cell Mater. 2020; 40:239-258.

PMID: 33206993 PMC: 7706585. DOI: 10.22203/eCM.v040a15.


Current strategies for treatment of intervertebral disc degeneration: substitution and regeneration possibilities.

van Uden S, Silva-Correia J, Oliveira J, Reis R Biomater Res. 2017; 21:22.

PMID: 29085662 PMC: 5651638. DOI: 10.1186/s40824-017-0106-6.


Optimization of Preculture Conditions to Maximize the In Vivo Performance of Cell-Seeded Engineered Intervertebral Discs.

Martin J, Gullbrand S, Mohanraj B, Ashinsky B, Kim D, Ikuta K Tissue Eng Part A. 2017; 23(17-18):923-934.

PMID: 28426371 PMC: 5610389. DOI: 10.1089/ten.tea.2016.0491.